Privia Health (PRVA Quick QuotePRVA - Free Report) reported $422.33 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 2.2%. EPS of $0.03 for the same period compares to $0.06 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $412.43 million, representing a surprise of +2.40%. The company delivered an EPS surprise of -40.00%, with the consensus EPS estimate being $0.05.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Privia Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Practice Collections

  : $728 million compared to the $711.39 million average estimate based on seven analysts.

• Care Margin

  : $99.80 million versus the six-analyst average estimate of $98.05 million.

• Platform Contribution

  : $47.40 million versus the six-analyst average estimate of $45.61 million.

• Implemented Providers (as of end of period)

  : 4,504 versus 4,369 estimated by three analysts on average.

• Attributed Lives (as of end of period)

  : 1.2 million compared to the 1.13 million average estimate based on three analysts.

View all Key Company Metrics for Privia Health here>>>

Shares of Privia Health have returned +6.8% over the past month versus the Zacks S&P 500 composite's -6.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.